DOI:
10.1055/s-00000094
Zeitschrift für Gastroenterologie
LinksClose Window
References
Herrmann R et al.
Gemcitabine (G) plus capecitabine (C) versus G alone in locally advanced or metastatic pancreatic cancer: a randomized phase III study of the Swiss Group for Clinical Cancer Research (SAKK) and the Central European Cooperative Oncology Group (CECOG).
J Clin Oncol 2005;
23 (Suppl. 16) A4010
Search in:
We do not assume any responsibility for the contents of the web pages of other providers.